Bayer AG Asset Turnover Growth & History (BAYN)
Bayer AG's asset turnover was 0.42 for fiscal 2025.
View full Bayer AG company overviewBayer AG annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.42 | 0.01 | +3.11% |
| 2024 | 2024-12-31 | 0.41 | 0.02 | +3.88% |
| 2023 | 2023-12-31 | 0.40 | −0.02 | −4.56% |
| 2022 | 2022-12-31 | 0.41 | 0.04 | +11.43% |
| 2021 | 2021-12-31 | 0.37 | 0.03 | +9.18% |
| 2020 | 2020-12-31 | 0.34 | −0.00 | −1.32% |
| 2019 | 2019-12-31 | 0.34 | −0.05 | −12.29% |
| 2018 | 2018-12-31 | 0.39 | −0.05 | −11.67% |
| 2017 | 2017-12-31 | 0.45 | −0.15 | −25.69% |
| 2016 | 2016-12-31 | 0.60 | −0.04 | −6.80% |
| 2015 | 2015-12-31 | 0.64 | −0.05 | −7.52% |
| 2014 | 2014-12-31 | 0.70 | −0.09 | −11.17% |
| 2013 | 2013-12-31 | 0.78 | 0.02 | +2.42% |
| 2012 | 2012-12-31 | 0.76 | 0.06 | +9.03% |
| 2011 | 2011-12-31 | 0.70 | — | — |
Bayer AG quarterly asset turnover
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.10 | — | — |
| Q1 2026 | 2026-03-31 | 0.13 | — | — |
| Q4 2025 | 2025-12-31 | 0.11 | — | — |
| Q3 2025 | 2025-09-30 | 0.09 | — | — |
Bayer AG asset turnover trends
Over the last five fiscal years, Bayer AG's asset turnover increased from 0.34 to 0.42, a change of 0.08. The latest reported quarter, Q2 2026, shows 0.10.
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bayer AG source filings ↗Community posts
Bayer wins the first Roundup trial following the Supreme Court ruling
A Missouri jury unanimously ruled for Bayer ($BAYN)’s Monsanto unit in a three-plaintiff Roundup case, rejecting design-defect, fraud and negligence claims. It was the first such trial following the US Supreme Court decision that blocked th ...
Bayer’s Nubeqa cuts risk of metastasis or death in prostate trial
Bayer ($BAYN) disclosed interim Phase 3 results showing that adding Nubeqa to hormone therapy and radiation reduced the risk of metastasis or death by 58% in prostate-cancer patients at high risk of recurrence. Four-year metastasis-free sur ...